BRTX

BioRestorative Therapies, Inc. (BRTX) | Rumor.io

BioRestorative Therapies

BRTX

Attention (50-day avg)0%

Attention rank (50-day avg)#2,271

Bullish sentiment (50-day avg)60%

Price to earnings ratio-1.46

Market capitalization3.2M

Earnings per share-21.2

Dividend yield (TTM)—

Revenue (annual)359.7K

Net income (annual)-14.2M

Social

What share of all stock conversation is about BRTX?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% +0	0% +0

Sep 8

BioRestorative Therapies, Inc. (BRTX) stock price has dropped below $1 in a month or less, and some investors are holding onto shares at $10.
The company's outstanding shares are approximately 1.4 million, which is considered a small float.
The BRTX-100 product is a viable stem cell treatment, and the biotech sector has shifted focus to small molecules, causing stem cells to be overlooked.

Generated by AI

Sentiment

Of the messages about BRTX that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	40% -4.44	89.27% +0.55
Bearish	—	—	60% +4.44	10.73% -0.55

Bullish· May 29

$BRTX has a low share structure, which could lead to a low-float scramble and a price increase to $0.9343 or $1.00.
BioRestorative Therapies, Inc. is oversold and due for a price increase, making it a good buy opportunity.
$BRTX has been building higher lows and is likely to have a big move next week, with some analysts predicting a price increase to $1.00 or double digits.

Bearish· May 29

The asset's price may fall to $0.30 due to dilution and regulatory scrutiny (RS).
The asset's price may experience a free fall after news of regulatory scrutiny (RS).
The asset's price may plummet to $0.10, and then double or triple digits due to a significant stake being taken.

Generated by AI

Topics

Of the messages about BRTX that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	100%	86.36%	63.94%
Controversies	—	0%	13.64%	0.28%
Analysts	—	0%	0%	0%
Earnings	—	0%	0%	0.09%
Macro	—	0%	0%	0%
Technical Analysis	—	0%	0%	35.68%

Announcements· May 27

BioRestorative Therapies, Inc. ($BRTX) has been acquired a 4.9% stake by Kaos Capital, an activist hedge fund, through open-market purchases.
Kaos Capital is urging the BRTX Board to discuss opportunities to unlock value for all shareholders, including a potential strategic review and pivot into AI.
BioRestorative Therapies has completed Phase 2 dosing of BRTX-100, a therapeutic product, and its Spine Program is advancing towards 2027 data.

Technical Analysis· Mar 10

$BRTX has been in a pennant formation, pressed along $0.33 support, and is waiting to break out to the $0.35 area.
A breakout for $BRTX requires volume to break the downtrend and the VWAP.
$BRTX has shown strong momentum, with a bullish flag pattern, surging volume, and an RSI in the overbought territory, indicating a potential breakout.

Generated by AI

Community

Of the messages about BRTX, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	88.89%	16.02%	34.72%
Newcomers	0%	11.11%	83.98%	65.28%

Regulars· May 27

$BRTX is experiencing high volatility, with a potential parabolic continuation and major price swings expected.
Kaos Capital's acquisition of a 4.9% stake in BioRestorative Therapies, Inc. may lead to a strategic review and AI pivot, potentially enhancing shareholder value.
$BRTX has a low float, with a significant portion of the shares available for trading, which could contribute to the stock's high volatility and potential price movements.

Newcomers· May 27

Newcomers are focusing on the potential for a "BANGER" stock, with one post mentioning a 200% runner and another highlighting the stock's clean price movement.
Several newcomers are discussing the stock's potential for a breakout, with one post suggesting a target of $0.59 on the daily and another mentioning the importance of holding above the $0.40 resistance level.
The stock's recent surge in price is being attributed to a 4.9% stake purchase by Kaos Capital, which is pushing the board to pivot into AI to "unlock shareholder value", according to one post.

Generated by AI

Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 90.6% to $3.87 during Wednesday's after-market session. The market value of their outstanding shares is at $1.7 million. Greenland Mines (NASDAQ:GRML) shares

6d agoBenzinga

BioRestorative Therapies reports resignation of vice president of R&D

18d agoInvesting.com

BioRestorative Therapies Announces Reverse Stock Split

MELVILLE, N.Y., Sept. 02, 2026 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (Nasdaq: BRTX) (“BioRestorative” or the “Company”), a late-stage clinical regenerative medicine company, today announced that the Company’s Board of Directors approved a 1-for-20 reverse stock split (the “Reverse Stock Split”) of the Company’s common stock (the “Common Stock”). The Company was not required to obtain stockholder approval to effectuate the Reverse Stock Split under Nevada law. The Company filed a cer

28d agoYahoo Finance

BioRestorative Therapies suspends shipments of ExoCR and BioX products for review

1mo agoInvesting.com

12 Health Care Stocks Moving In Wednesday's After-Market Session - OSR Health (NASDAQ:OSRH), BioRestorati

Gainers OSR Health (NASDAQ:OSRH) stock increased by 7.2% to $0.33 during Wednesday's after-market session. The company's market cap stands at $11.0 million. BioRestorative Therapies (NASDAQ:BRTX) stock moved

2mo agoBenzinga

Also Discussed

Investors talking about BRTX also mention

#	Name	Attention
1	Creative Medical Technology Holdings, Inc.CELZ	0%0
2	SGN - Signing Day Sports, Inc.	——
3	Linkers Industries LimitedLNKS	0%0
4	UOKA - MDJM Ltd	——
5	La Rosa Holdings Corp.LRHC	0%0
6	Silo Pharma Inc.SILO	0%new
7	Addentax Group Corp.ATXG	0%0
8	Aspire Biopharma Holdings, Inc.ASBP	0%new
9	ALPP - Alpine 4 Holdings, Inc.	——
10	Shengfeng Development Ltd.SFWL	0%0

BioRestorative Therapies, Inc.

Healthcare
Biotechnology

BioRestorative Therapies Inc. is a biotechnology company focused on developing regenerative medicine products and therapies using cell and tissue protocols, primarily based on adult stem cells. BioRestorative Therapies Inc. centers its current work on two main programs: a disc and spine therapy platform for degenerative disc disease and chronic back pain, and a metabolic disease platform aimed at obesity and related disorders. Its pipeline includes BRTX-100, an autologous cell therapy candidate designed for spinal applications, and ThermoStem, a cell-based program built around brown adipose tissue biology. The company also works with an investigational delivery device for spine and disc treatments and operates a commercial biocosmeceutical platform. Based in Melville, New York, BioRestorative Therapies Inc. participates in the broader biotechnology and regenerative medicine market, where it develops treatment approaches intended to address unmet medical needs in musculoskeletal and metabolic health.

Website

Location

40 Marcus Drive

Melville, NY, 11747

United States

Social

What share of all stock conversation is about BRTX?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% +0	0% +0

Sep 8

BioRestorative Therapies, Inc. (BRTX) stock price has dropped below $1 in a month or less, and some investors are holding onto shares at $10.
The company's outstanding shares are approximately 1.4 million, which is considered a small float.
The BRTX-100 product is a viable stem cell treatment, and the biotech sector has shifted focus to small molecules, causing stem cells to be overlooked.

Generated by AI

Sentiment

Of the messages about BRTX that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	40% -4.44	89.27% +0.55
Bearish	—	—	60% +4.44	10.73% -0.55

Bullish· May 29

$BRTX has a low share structure, which could lead to a low-float scramble and a price increase to $0.9343 or $1.00.
BioRestorative Therapies, Inc. is oversold and due for a price increase, making it a good buy opportunity.
$BRTX has been building higher lows and is likely to have a big move next week, with some analysts predicting a price increase to $1.00 or double digits.

Bearish· May 29

The asset's price may fall to $0.30 due to dilution and regulatory scrutiny (RS).
The asset's price may experience a free fall after news of regulatory scrutiny (RS).
The asset's price may plummet to $0.10, and then double or triple digits due to a significant stake being taken.

Generated by AI

Topics

Of the messages about BRTX that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	100%	86.36%	63.94%
Controversies	—	0%	13.64%	0.28%
Analysts	—	0%	0%	0%
Earnings	—	0%	0%	0.09%
Macro	—	0%	0%	0%
Technical Analysis	—	0%	0%	35.68%

Announcements· May 27

BioRestorative Therapies, Inc. ($BRTX) has been acquired a 4.9% stake by Kaos Capital, an activist hedge fund, through open-market purchases.
Kaos Capital is urging the BRTX Board to discuss opportunities to unlock value for all shareholders, including a potential strategic review and pivot into AI.
BioRestorative Therapies has completed Phase 2 dosing of BRTX-100, a therapeutic product, and its Spine Program is advancing towards 2027 data.

Technical Analysis· Mar 10

$BRTX has been in a pennant formation, pressed along $0.33 support, and is waiting to break out to the $0.35 area.
A breakout for $BRTX requires volume to break the downtrend and the VWAP.
$BRTX has shown strong momentum, with a bullish flag pattern, surging volume, and an RSI in the overbought territory, indicating a potential breakout.

Generated by AI

Community

Of the messages about BRTX, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	88.89%	16.02%	34.72%
Newcomers	0%	11.11%	83.98%	65.28%

Regulars· May 27

$BRTX is experiencing high volatility, with a potential parabolic continuation and major price swings expected.
Kaos Capital's acquisition of a 4.9% stake in BioRestorative Therapies, Inc. may lead to a strategic review and AI pivot, potentially enhancing shareholder value.
$BRTX has a low float, with a significant portion of the shares available for trading, which could contribute to the stock's high volatility and potential price movements.

Newcomers· May 27

Newcomers are focusing on the potential for a "BANGER" stock, with one post mentioning a 200% runner and another highlighting the stock's clean price movement.
Several newcomers are discussing the stock's potential for a breakout, with one post suggesting a target of $0.59 on the daily and another mentioning the importance of holding above the $0.40 resistance level.
The stock's recent surge in price is being attributed to a 4.9% stake purchase by Kaos Capital, which is pushing the board to pivot into AI to "unlock shareholder value", according to one post.

Generated by AI

BioRestorative Therapies

Social

Sep 8

Sentiment

Bullish· May 29

Bearish· May 29

Topics

Announcements· May 27

Technical Analysis· Mar 10

Community

Regulars· May 27

Newcomers· May 27

News

12 Health Care Stocks Moving In Wednesday's After-Market Session - GlucoTrack (NASDAQ:GCTK), Greenland Mi

BioRestorative Therapies reports resignation of vice president of R&D

BioRestorative Therapies Announces Reverse Stock Split

BioRestorative Therapies suspends shipments of ExoCR and BioX products for review

12 Health Care Stocks Moving In Wednesday's After-Market Session - OSR Health (NASDAQ:OSRH), BioRestorati

Also Discussed

BioRestorative Therapies, Inc.

Company Information

Location

News

12 Health Care Stocks Moving In Wednesday's After-Market Session - GlucoTrack (NASDAQ:GCTK), Greenland Mi

BioRestorative Therapies reports resignation of vice president of R&D

BioRestorative Therapies Announces Reverse Stock Split

BioRestorative Therapies suspends shipments of ExoCR and BioX products for review

12 Health Care Stocks Moving In Wednesday's After-Market Session - OSR Health (NASDAQ:OSRH), BioRestorati

Also Discussed

Social

Sep 8

Sentiment

Bullish· May 29

Bearish· May 29

Topics

Announcements· May 27

Technical Analysis· Mar 10

Community

Regulars· May 27

Newcomers· May 27